Katsiaryna Chuprasava, MD
Family Medicine · Acworth, GANPI 1851504641
Payments from drug & device makers
Across 364 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$960
- Novo Nordisk$722
- Boehringer Ingelheim$496
- Lilly USA, LLC$489
- Amgen$479
- AstraZeneca$424
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,364100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 93 | $960 |
| Novo Nordisk | 45 | $722 |
| Boehringer Ingelheim | 30 | $496 |
| Lilly USA, LLC | 30 | $489 |
| Amgen(2 entities) | 33 | $479 |
| AstraZeneca | 28 | $424 |
| GSK | 20 | $373 |
| Pfizer | 16 | $246 |
| Exact Sciences | 7 | $118 |
| Abbott | 7 | $118 |
| Merck | 7 | $102 |
| Astellas Pharma US Inc | 4 | $86 |
| Dexcom, Inc. | 3 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Amarin Pharma, Inc. | 4 | $59 |
| Johnson & Johnson(2 entities) | 4 | $57 |
| Bayer | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Eisai Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Novartis | 1 | $23 |
| Shield Therapeutics Inc | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Vivus LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Bausch Health US, LLC | 1 | $15 |
How this compares
$5,378 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 140 | $188,433 |
| MounjaroTirzepatide | 79 | $99,580 |
| JardianceEmpagliflozin | 69 | $87,411 |
| FarxigaDapagliflozin Propanediol | 62 | $69,605 |
| EliquisApixaban | 56 | $64,237 |
| LinzessLinaclotide | 30 | $33,534 |
| XareltoRivaroxaban | 37 | $32,622 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $31,819 |
| Repatha SureclickEvolocumab | 28 | $25,926 |
| JanuviaSitagliptin Phosphate | 24 | $24,127 |
| ProliaDenosumab | 14 | $23,810 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $13,656 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $13,450 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $12,155 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $7,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $722 | $188,433140 claims |
| Lilly USA, LLCMounjaro, Humulin 70-30 | $489 | $100,75991 claims |
| Boehringer IngelheimJardiance | $496 | $87,41169 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $424 | $83,26173 claims |
| PfizerEliquis | $246 | $64,23756 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $373 | $37,21831 claims |
| AbbVieLinzess, Synthroid | $960 | $36,67261 claims |
| Johnson & JohnsonXarelto | $57 | $32,62237 claims |
| MerckJanuvia | $102 | $24,12724 claims |
| AmgenProlia | $479 | $23,81014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Acworth
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.